Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-05 4:11 pm Purchase | 13D | NAMPHASE TECHNOLOGIES CORP NANX | WHITMORE BRADFORD T | 49,826,805 71.5% | 15,000,000 (+43.07%) | View |
| 2024-02-12 5:07 pm Purchase | 13D | NAMPHASE TECHNOLOGIES CORP NANX | WHITMORE BRADFORD T | 34,826,805 63.7% | 3,818,527 (+12.31%) | View |
| 2023-11-16 09:03 am Purchase | 13D | NAMPHASE TECHNOLOGIES CORP NANX | WHITMORE BRADFORD T | 31,008,278 62.4% | 730,124 (+2.41%) | View |
| 2023-11-01 4:04 pm Purchase | 13G | CLEARSIDE BIOMEDICAL INC CLSD | WHITMORE BRADFORD T | 6,264,964 10.1% | 247,112 (+4.11%) | View |
| 2023-01-04 12:06 pm Purchase | 13G | CLEARSIDE BIOMEDICAL INC CLSD | WHITMORE BRADFORD T | 6,017,852 9.9% | 139,655 (+2.38%) | View |
| 2022-01-24 4:03 pm Sale | 13G | CLEARSIDE BIOMEDICAL INC CLSD | WHITMORE BRADFORD T | 5,878,197 9.9% | -486,989 (-7.65%) | View |
| 2021-12-23 4:01 pm Purchase | 13D | NAMPHASE TECHNOLOGIES CORP NANX | WHITMORE BRADFORD T | 30,278,154 62.1% | 95,555 (+0.32%) | View |
| 2021-01-07 11:10 am Purchase | 13G | CLEARSIDE BIOMEDICAL INC CLSD | WHITMORE BRADFORD T | 6,365,186 11.1% | 929,845 (+17.11%) | View |
| 2020-11-06 2:38 pm Purchase | 13D | ULTRALIFE CORPORATION COM ULBI | WHITMORE BRADFORD T | 5,538,073 34.8% | 395,347 (+7.69%) | View |
| 2020-11-06 2:21 pm Unchanged | 13D | NAMPHASE TECHNOLOGIES CORP NANX | WHITMORE BRADFORD T | 30,182,599 62.7% | 0 (Unchanged) | View |
| 2020-10-01 4:47 pm Unchanged | 13D | NAMPHASE TECHNOLOGIES CORP NANX | WHITMORE BRADFORD T | 30,182,599 62.7% | 0 (Unchanged) | View |
| 2019-11-26 12:58 pm Purchase | 13G | CLEARSIDE BIOMEDICAL INC CLSD | WHITMORE BRADFORD T | 5,435,341 12.3% | 2,235,341 (+69.85%) | View |
| 2019-11-15 5:14 pm Purchase | 13D | NAMPHASE TECHNOLOGIES CORP NANX | WHITMORE BRADFORD T | 30,182,599 62.7% | 10,000,000 (+49.55%) | View |
| 2019-05-15 5:15 pm Purchase | 13D | NAMPHASE TECHNOLOGIES CORP NANX | WHITMORE BRADFORD T | 20,182,599 53% | 4,189,000 (+26.19%) | View |